Bleomycin therapy of experimental disseminated candidiasis in mice

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 816-818

  Graybill, John R ^a,b   Bocanegra, Rosie ^a   Fothergill, Annette ^a   Rinaldi, Michael G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Audie L Murphy Memorial Veterans Administration Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FUNGICIDAL ACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME;

EID: 0030069094     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.816     Document Type: Article

References (13)

1. Beaudouin, R., S. T. Lim, J. A. Steide, M. Powell, J. McKoy, A. J. Pramanik, E. Johnson, C. W. Moore, and P. N. Lipke. 1993. Bleomycin affects cell wall anchorage of mannoproteins in Saccharomyces cerevisiae Antimicrob. Agents Chemother 37:1264-1269.
2. Everson, M. P., and D. S. Chandler. 1992. Changes in the distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycm-induced pulmonary fibrosis. Am. J. Pathol 140:503-512.
3. Huttenhofer, A., S. Hudson, H. F. Noller, and P. K. Mascharak. 1992. Cleavage of tRNA by bleomycin. J. Biol Chem. 267:24471-24495
4. Micallef, M. 1993. Immunoregulatory cytokine production by tumor bearing rat spleen ceils and its modulation by bleomycin. Anticancer Drugs 4:213-222
5. Moore, C. W. 1988. Bleomycin-induced DNA repair by Saccharomyces cerevisiae ATP-dependent polyribonucleotide ligase. J. Bacteriol. 170:4991-4994.
6. Moore, C. W. 1991. Further characterizations of bleomycin-sensitive (blm) mutants of Saccharomyces cerevisiae with implications for a radiomimetic model. J Bacteriol. 173:3605-3608.
7. Moore, C. W. 1994 Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 38:1615-1619
8. 2 on Saccharomyces cerevisiae cell walls and membranes. Antimicrob. Agents Chemother. 36:2497-2505.
9. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeast. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Phan, S. H., and S. L. Kunkel. 1992 Lung cytokine production in bleomycininduced pulmonary fibrosis. Exp. Lung Res, 18:29-43.
11. Piguet, P. F., C. Vesin, G. E. Grau, and R. C. Thompson. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57-61.
12. Stubbe, J., and J. W. Kozarich. 1987. Mechanisms of bleomycin-induced DNA degradation. Chem. Rev. 87:1107-1136.
13. Velez, J. D., R. Allendoerfer, M. Luther, M. G. Rinaldi, and J. R. Grayhill. 1993. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J. Infect Dis. 168:508-510.